NIDDK Funding Opportunity

DP3 Type 1 Diabetes Targeted Research Award

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)

This FOA invites applications for ancillary studies using archived samples from selected diabetes clinical trials and studies.  Ancillary studies are expected to generate scientific discoveries on type 1 diabetes primary pathogenesis or the pathogenesis of complications, and biomarkers of disease progression or clinical responses to interventions. 

Full AnnouncementPAR-14-065
Open Date3/10/2014
Letter of Intent Due Date
March 10, 2014
Application Due Date
April 10, 2014, by 5:00 PM local time of applicant organization.
NIDDK Program ContactLisa M. Spain, Ph.D.

Print Page

Click outside of the light box to close the box.